Journal of Clinical Biochemistry and Nutrition
Online ISSN : 1880-5086
Print ISSN : 0912-0009
ISSN-L : 0912-0009
Original Articles
Advanced Glycation Endproducts Act as An Initiator of Skin Tumors in Mice
Masakazu OgataGoji HasegawaNaoto NakamuraHiroshi ObayashiToshikazu YoshikawaHoyoku NishinoHarukuni Tokuda
著者情報
ジャーナル フリー

2006 年 38 巻 3 号 p. 176-179

詳細
抄録

The role of advanced glycation endproducts (AGEs) as the initiator of tumor induction was investigated in SENCAR mice. Initiation with AGEs-modified bovine serum albumin (AGEs–BSA) increased both the incidence of tumor-bearing mice and the mean number of tumors per mouse. An immunohistochemical study revealed an increase in 8-hydroxy-2'-deoxyguanosine (8-OhdG) in nuclei of epidermal cells in the AGEs-BSA treated mice. Furthermore, a Salmonella mutagenicity test revealed that AGEs-BSA was mutagenic only in Salmonella TA104, a strain more sensitive to oxidative stress than other strains. These results suggest that AGEs are mutagenic through a mechanism associated with oxidative stress.

著者関連情報
© 2006 by The Editorial Secretariat of JCBN
前の記事 次の記事
feedback
Top